Home > Boards > US OTC > Miscellaneous > IIOT-OXYS Inc. (ITOX)

ITOX, CEO Cliff Emmons Resume with Medtronics

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
TripTrap Member Profile
 
Followed By 13
Posts 570
Boards Moderated 1
Alias Born 05/01/18
160x600 placeholder
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 11/24/2020 2:15:49 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/16/2020 5:12:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2020 4:32:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2020 4:32:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2020 1:28:25 PM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 10/5/2020 4:52:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/25/2020 6:05:41 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 9/14/2020 2:10:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/1/2020 8:00:52 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/19/2020 1:34:44 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/17/2020 4:10:38 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 8/14/2020 6:05:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/3/2020 8:46:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/31/2020 9:08:59 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/6/2020 5:18:38 PM
Annual Report (10-k) Edgar (US Regulatory) - 6/23/2020 6:03:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/17/2020 3:05:34 PM
Amended Small Company Offering and Sale of Securities Without Registration (d/a) Edgar (US Regulatory) - 6/3/2020 10:32:09 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/29/2020 8:31:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/22/2020 1:21:44 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 5/15/2020 8:59:53 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2020 5:26:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/1/2020 8:31:03 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/27/2020 12:38:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/19/2020 6:05:57 AM
TripTrap   Wednesday, 04/29/20 11:21:46 PM
Re: None
Post # of 5275 
ITOX, CEO Cliff Emmons Resume with Medtronics
https://www.linkedin.com/in/cliff-emmons/

2005 – 2010
Director, Engineering Services
North Haven, CT
Led a multi-disciplined team using internal and external resources to provide Industrial Design, Rapid Prototyping, and Pilot Tooling services to global development teams. Leveraged Indian Engineering Service Providers (ESPs) to augment capabilities of global R&D teams, earning the inagural Covidien Emerging Markets Innovation Award. Led a cross-functional team that developed the first "local for local" product for the emerging markets leveraging Indian ESPs. Partnered with an internal team and McKinsey & Co. consultants to secure BOD approved funding to establish Covidien's China R&D and India engineering centers.

2010 – 2013
Vice President, Tailored Products - Emerging Markets
Singapore
Envisioned and established a greenfield R&D center in Shanghai, specifically created for localized ("tailored") products for the emerging markets. Vetted and hired the initial local (Chinese National) director-level leaders. Rapidly led technology transfer from global R&D to nascent China teams. Worked with CTO to hire and partner with a Chinese National (repatriated) as VP China R&D of the Shanghai site. Launched the first products from center within first year of operation. Established the initial product portfolio that resulted in more than a dozen products launched within five years with multi-million USD annual revenue growing at double digit rates.

2013 – 2017
Vice President Extended R&D MITG
Mansfield, MA
Created and led extended R&D teams collocated at Medtronic Innovation Centers (MICs) based in Seoul & Osong, South Korea; Istanbul, Turkey; and Sao Paulo, Brazil. Designed, built, equipped, and commissioned all three R&D labs, elevating training facilities to innovation centers. Envisioned group charter, hired, trained, and coached the leaders and staff - creating effective "extended" team members for global development teams. Through deep "voice of customer" skills and technology scouting, developed a robust "bullpen" of projects for the global and localized product portfolios.

2015 – 2017
Vice President, R&D India & Extended Emerging Markets
Mansfield, MA, USA
Reported to the President of the Patient Monitoring & Recovery (PMR) business unit, chaired the PMR R&D Council, instituted operating principles resulting in visibility and accountabilty of R&D projects, and unlocked funding for critical new projects.

Led the Medtronic Engineering & Innovation Center (MEIC) in Hyderabad, India for the Minimally Invasive Therapies Group (formerly Covidien), with over 200 engineers. Continued responsibility for the extended emerging markets R&D teams. Transformed MEIC from a pure Engineering Services team to a full-fledged R&D center, including launching the center's first PMA (Class 3) device, and bringing team morale to an all-time high.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences